Well, this sounds scary as sh*t!
The Trump White House today announced plans for the Department of Health and the Department of Defense to team up and deliver a vaccine for the coronavirus.
At least 14% of adults will refuse this vaccine. What will they do then?
General Gustave Perna excitedly announced the partnership today.
The only reason this team was announced is because Dr. Fauci, who has been wrong on everything, moved the goalposts and pushed for a vaccine on this flu-like disease.
It went from “flatten the curve” to “find the cure”. From “social distancing” to “house arrest”. From “2 weeks” to “3 months”. From “we’re in it together” to “snitch on you neighbors”. From “individual liberty” to “comply or pay fine”. We lost the target. And government knows it.
— Viva Frei (@thevivafrei) May 15, 2020
President Trump has chosen a former pharmaceutical executive and a four star general to run Operation Warp Speed, an effort to speed up development of a vaccine for COVID-19 and get it to as many Americans as quickly as possible.
“I think we’re going to have a vaccine by the end of the year, and I think distribution will take place almost simultaneously because we’ve geared up the military,” President Trump said as he prepared to board Marine One on Thursday afternoon. Experts have said the best case scenario for vaccine development would be 12 to 18 months.
It’s not clear exactly what he means by gearing up the military, but Trump could be referencing the addition of General Gustave Perna to the Operation Warp Speed team. Perna is commander of the U.S. Army Materiel Command and, according to two administration officials, will be the chief operating officer of the program.
Former GlaxoSmithKline executive Moncef Slaoui has been named chief adviser to the effort. He held numerous roles at the company over a long career, including chairman of global vaccines. Since his retirement, Slaoui has served on pharmaceutical and health tech company boards, including Moderna, the company whose vaccine Dr. Anthony Fauci of the National Institutes of Health has described as promising. Among numerous candidates, that vaccine is the furthest along in development, entering a phase 2 trial.
Read the Original Article Here